Blood thinner causes stroke in some dialysis patients

August 27, 2009

The blood thinner warfarin can prevent strokes in most individuals with abnormal heart rhythms, but the drug may have the opposite effect in kidney disease patients on dialysis, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results suggest that warfarin should be prescribed with caution in patients with kidney failure.

People with atrial fibrillation, the most common type of , have a significantly increased risk of . Blood thinners can mitigate this risk. However, almost no studies have examined whether can also prevent stroke in atrial fibrillation patients who are also on dialysis.

To investigate, Kevin Chan, MD, Michael Lazarus, MD, Raymond Hakim, MD, PhD (Fresenius Medical Care North America); and Ravi Thadhani, MD (Massachusetts General Hospital), studied 1,671 end stage renal disease (ESRD) patients with a diagnosis of atrial fibrillation who started dialysis in clinics operated by Fresenius Medical Care North America. Patients' health was monitored for an average of 1.6 years after dialysis was started.

The researchers found that patients who took warfarin increased their risk of stroke; however, the increase in risk was related to the degree of blood thinning in response to the drug. Dialysis patients whose blood was not monitored for warfarin levels after they received the drug had the highest risk of stroke (almost three-fold higher than patients not on warfarin). Notably, clopidogrel and aspirin—two other types of blood thinners—did not increase dialysis patients' risk of stroke.

Additional research is needed to determine why warfain has the opposite effect on stroke risk in kidney disease patients on dialysis compared with other individuals. One possible explanation maybe because bleeding is a well known complication of and the concomitant use of blood thinners may exaggerate the risk of stroke from bleeding in the head. Also, this study's findings should be validated through randomized controlled clinical trials. "Until then, physicians should be cognizant of the possible risks associated with warfarin use for atrial fibrillation in ESRD patients with careful evaluation of the risks and benefits of intervention at the individual patient level," they concluded.

More information: The article, entitled "Warfarin Use Associates with Increased Risk for Stroke in Hemodialysis Patients with ," will appear online on August 27, 2009, doi 10.1681/ASN.2009030319

Source: American Society of Nephrology (news : web)

Related Stories

Recommended for you

Zika virus infection alters human and viral RNA

October 20, 2016

Researchers at University of California San Diego School of Medicine have discovered that Zika virus infection leads to modifications of both viral and human genetic material. These modifications—chemical tags known as ...

Food-poisoning bacteria may be behind Crohn's disease

October 19, 2016

People who retain a particular bacterium in their gut after a bout of food poisoning may be at an increased risk of developing Crohn's disease later in life, according to a new study led by researchers at McMaster University.

Neurodevelopmental model of Zika may provide rapid answers

October 19, 2016

A newly published study from researchers working in collaboration with the Regenerative Bioscience Center at the University of Georgia demonstrates fetal death and brain damage in early chick embryos similar to microcephaly—a ...

Scientists uncover new facets of Zika-related birth defects

October 17, 2016

In a study that could one day help eliminate the tragic birth defects caused by Zika virus, scientists from the Florida campus of The Scripps Research Institute (TSRI) have elucidated how the virus attacks the brains of newborns, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.